Jonathan Melius
Surgical · Trenton, NJNPI 1194034157
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 284 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 25.3% of the total. 2025 is the largest year on record at $2,560, more than ten times the $108 reported in 2022. Among surgical clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 284 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$852
- Johnson & Johnson$541
- Teva Pharmaceuticals USA, Inc.$323
- Corium, LLC$303
- Otsuka America Pharmaceutical, Inc.$299
- plus $2K from 15 others
What the payments were for
- Food & beverage$5,33997%
- Education$1583%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $1,392 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 49 | $852 |
| Johnson & Johnson | 28 | $541 |
| Teva Pharmaceuticals USA, Inc. | 13 | $323 |
| Corium, LLC | 25 | $303 |
| Otsuka America Pharmaceutical, Inc. | 14 | $299 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $259 |
| Lundbeck LLC | 12 | $253 |
| Axsome Therapeutics, Inc. | 12 | $237 |
| Neurocrine Biosciences, Inc. | 12 | $222 |
| Supernus Pharmaceuticals, Inc. | 7 | $137 |
| Idorsia Pharmaceuticals US Inc | 7 | $130 |
| Bausch Health US, LLC | 6 | $122 |
| Alkermes, Inc. | 4 | $100 |
| E.r. Squibb & Sons, L.L.C. | 4 | $92 |
| Collegium Pharmaceutical, Inc. | 3 | $69 |
| Ironshore Pharmaceuticals Inc. | 3 | $68 |
| Integra Lifesciences Corporation | 1 | $32 |
| Vanda Pharmaceuticals Inc. | 2 | $28 |
| Indivior Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $19 |
How this compares
$5,498 in reported general payments places this provider in the 90th percentile of 462 surgical providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 23 | $46,539 |
| TrintellixVortioxetine Hydrobromide | 75 | $37,587 |
| VraylarCariprazine Hcl | 20 | $28,788 |
| Lurasidone Hcl | 38 | $28,210 |
| RexultiBrexpiprazole | 14 | $20,220 |
| AuvelityDextromethorphan Hbr/Bupropion | 12 | $12,858 |
| Aripiprazole | 138 | $6,321 |
| Bupropion XlBupropion Hcl | 136 | $2,874 |
| Duloxetine Hcl | 64 | $2,191 |
| Paliperidone ErPaliperidone | 11 | $1,812 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 103 | $1,469 |
| Escitalopram Oxalate | 111 | $1,412 |
| Quetiapine Fumarate | 69 | $1,263 |
| Trazodone Hcl | 116 | $1,120 |
| Clonazepam | 114 | $1,088 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $852 | $46,53923 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $259 | $37,58775 claims |
| AbbVieVraylar | $1,392 | $28,78820 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $299 | $20,22014 claims |
| Axsome Therapeutics, Inc.Auvelity | $237 | $12,85812 claims |
| Almatica Pharma LLCSertraline Hcl | $19 | $77841 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 462 surgical providers in New Jersey.
Other surgical in Trenton
- Matthew PetridesNeptune$183K
- Andrea ConwayCherry Hill$105K
- Dean BaroneUnion$69K
- Jessica HendersonEatontown$53K
- Richard BengelCamden$44K
- Dylan RyanCamden$26K
- Lauren RoyceClifton$11K
- Rachel WintMount Laurel$10K
- Richard HulseNeptune$10K
- Mimi OliffWest Orange$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.